Herbalife (HLF) Financials

$7.84 +0.20 (+2.58%)

As of 09:35 AM Eastern

Annual Income Statements for Herbalife

This table shows Herbalife's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	254	142	321	447	373	280	297	214	260	339	309
Consolidated Net Income / (Loss)	254	142	321	447	373	311	297	214	260	339	309
Net Income / (Loss) Continuing Operations	254	142	321	447	373	280	297	214	260	339	309
Total Pre-Tax Income	169	203	425	561	516	451	464	471	365	486	421
Total Operating Income	386	356	545	734	641	568	683	617	458	584	514
Total Gross Profit	3,889	3,871	4,031	4,564	4,391	3,919	3,973	3,579	3,634	3,613	3,976
Total Revenue	4,993	5,062	5,204	5,803	5,542	4,877	4,892	4,428	4,488	4,469	4,959
Operating Revenue	4,993	5,062	5,204	5,803	5,542	4,877	4,892	4,428	4,488	4,469	4,959
Total Cost of Revenue	1,104	1,191	1,174	1,239	1,151	958	919	849	855	856	983
Operating Cost of Revenue	1,104	1,191	1,174	1,239	1,151	958	919	849	855	856	983
Total Operating Expenses	3,503	3,515	3,486	3,829	3,751	3,351	3,289	2,962	3,176	3,029	3,462
Selling, General & Admin Expense	1,875	1,866	1,810	2,012	2,075	1,940	1,955	1,759	1,967	1,785	1,991
Other Operating Expenses / (Income)	1,628	1,649	1,675	1,817	1,676	1,411	1,334	1,203	1,209	1,245	1,471
Total Other Income / (Expense), net	-217	-153	-120	-173	-124	-148	-219	-146	-93	-97	-92
Interest Expense	218	166	139	153	133	153	181	161	99	101	92
Interest & Investment Income	12	12	6.10	4.40	8.80	21	19	15	5.90	5.60	13
Other Income / (Expense), net	-11	1.00	13	-25	0.00	-16	-57	0.40	-	-2.30	-13
Income Tax Expense	-85	61	104	114	144	140	168	257	105	147	113
Basic Earnings per Share	$2.53	$1.44	$3.26	$4.22	$2.83	$2.26	$2.12	$1.35	$1.57	$4.11	$3.58
Weighted Average Basic Shares Outstanding	100.60M	99M	98.50M	105.90M	131.50M	137.40M	140.20M	158.50M	166.10M	82.60M	86.30M
Diluted Earnings per Share	$2.50	$1.42	$3.23	$4.13	$2.77	$2.20	$1.98	$1.29	$1.51	$3.97	$3.40
Weighted Average Diluted Shares Outstanding	101.60M	100.20M	99.50M	108.30M	134.50M	141.60M	149.50M	165.70M	172.20M	85.30M	90.80M
Weighted Average Basic & Diluted Shares Outstanding	101.20M	99.26M	97.92M	109.77M	117.92M	147.53M	139.90M	158.40M	83.10M	82.50M	86.20M

This table shows Herbalife's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	178	47	4.70	24	10	43	60	29	54	82
Consolidated Net Income / (Loss)	178	47	4.70	24	10	43	60	29	54	82
Net Income / (Loss) Continuing Operations	178	47	4.70	24	10	43	60	29	54	82
Total Pre-Tax Income	53	71	12	34	18	69	85	31	64	113
Total Operating Income	107	127	80	72	56	107	123	71	89	147
Total Gross Profit	940	972	998	979	927	978	1,012	954	915	1,010
Total Revenue	1,207	1,240	1,281	1,264	1,215	1,281	1,314	1,252	1,181	1,295
Operating Revenue	1,207	1,240	1,281	1,264	1,215	1,281	1,314	1,252	1,181	1,295
Total Cost of Revenue	268	269	283	285	288	303	302	299	266	285
Operating Cost of Revenue	268	269	283	285	288	303	302	299	266	285
Total Operating Expenses	833	845	918	907	872	871	889	883	826	863
Selling, General & Admin Expense	437	444	502	492	474	455	461	476	437	448
Other Operating Expenses / (Income)	397	401	415	415	397	416	429	407	389	414
Total Other Income / (Expense), net	-54	-57	-68	-38	-38	-38	-38	-39	-25	-35
Interest Expense	66	57	58	38	50	39	38	39	43	35
Income Tax Expense	-125	23	7.50	9.70	7.50	26	25	1.80	10	31
Basic Earnings per Share	$1.77	$0.47	$0.05	$0.24	$0.11	$0.43	$0.60	$0.30	$0.56	$0.84
Weighted Average Basic Shares Outstanding	100.60M	100.90M	100.60M	99.70M	99M	99.20M	99.10M	98.50M	98.50M	98M
Diluted Earnings per Share	$1.75	$0.46	$0.05	$0.24	$0.10	$0.43	$0.60	$0.29	$0.56	$0.83
Weighted Average Diluted Shares Outstanding	101.60M	101.90M	101.70M	100.70M	100.20M	100.40M	99.50M	100.20M	99.50M	98.80M
Weighted Average Basic & Diluted Shares Outstanding	101.20M	100.79M	100.72M	99.97M	99.26M	99.11M	99.00M	98.92M	97.92M	97.88M

This table details how cash moves in and out of Herbalife's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-157	79	-94	-444	207	-368	-29	410	-27	244	-328
Net Cash From Operating Activities	285	358	353	460	629	458	648	591	367	629	511
Net Cash From Continuing Operating Activities	285	358	353	460	629	458	648	591	367	629	511
Net Income / (Loss) Continuing Operations	254	142	321	447	373	311	297	214	260	339	309
Consolidated Net Income / (Loss)	254	142	321	447	373	311	297	214	260	339	309
Depreciation Expense	121	113	115	108	100	98	100	100	98	98	93
Amortization Expense	13	7.40	6.70	30	27	44	64	60	56	56	44
Non-Cash Adjustments To Reconcile Net Income	105	82	53	145	148	63	139	73	48	108	288
Changes in Operating Assets and Liabilities, net	-208	13	-143	-269	-19	-58	48	144	-95	28	-222
Net Cash From Investing Activities	-85	-135	-156	-156	-123	-108	-84	-95	-142	-73	-201
Net Cash From Continuing Investing Activities	-85	-135	-156	-156	-123	-108	-84	-95	-142	-73	-201
Purchase of Property, Plant & Equipment	-122	-135	-156	-151	-112	-106	-84	-96	-143	-79	-189
Other Investing Activities, net	37	0.20	0.20	-5.00	-11	-1.90	0.10	0.30	1.00	5.70	-
Net Cash From Financing Activities	-335	-148	-265	-729	-321	-713	-593	-85	-252	-250	-390
Net Cash From Continuing Financing Activities	-335	-148	-265	-729	-321	-713	-593	-85	-252	-250	-390
Repayment of Debt	-2,500	-353	-960	-988	-29	-696	-1,850	-517	-439	-234	-160
Repurchase of Common Equity	-8.30	-11	-147	-1,011	-924	-17	-750	-844	-13	-17	-1,292
Issuance of Debt	2,173	215	842	1,271	632	0.00	1,951	1,276	200	0.40	1,203
Effect of Exchange Rate Changes	-23	4.80	-	-19	22	-4.00	-	-	-	-61	-248
Cash Interest Paid	194	159	134	144	79	114	106	101	45	51	39
Cash Income Taxes Paid	147	133	145	156	138	148	159	159	163	168	181

This table details how cash moves in and out of Herbalife's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	20	29	-23	-183	80	-31	86	-55	-24	-49
Net Cash From Operating Activities	70	100	103	14	96	80	136	46	54	70
Net Cash From Continuing Operating Activities	70	100	103	14	96	80	136	46	54	70
Net Income / (Loss) Continuing Operations	178	47	4.70	24	10	43	60	29	54	82
Consolidated Net Income / (Loss)	178	47	4.70	24	10	43	60	29	54	82
Depreciation Expense	29	31	33	29	28	28	29	28	28	29
Amortization Expense	4.00	3.80	3.50	2.10	1.90	1.90	1.90	1.70	1.70	1.70
Non-Cash Adjustments To Reconcile Net Income	27	44	45	-11	34	26	26	-3.80	7.70	21
Changes in Operating Assets and Liabilities, net	-168	-26	17	-31	22	-20	19	-8.60	-38	-64
Net Cash From Investing Activities	-26	10	-36	-33	-35	-31	-38	-30	-43	-38
Net Cash From Continuing Investing Activities	-26	10	-36	-33	-35	-31	-38	-30	-43	-38
Purchase of Property, Plant & Equipment	-26	-27	-36	-33	-35	-31	-38	-30	-43	-38
Other Investing Activities, net	0.10	37	0.10	0.10	0.10	-	-	0.10	-	0.10
Net Cash From Financing Activities	-9.00	-86	-82	-158	8.30	-71	-9.30	-76	-50	-56
Net Cash From Continuing Financing Activities	-9.00	-86	-82	-158	8.30	-71	-9.30	-76	-50	-56
Repayment of Debt	-283	-242	-1,658	-317	-11	-195	-8.60	-138	-458	-330
Repurchase of Common Equity	-2.60	-	-3.40	-2.30	-1.30	-0.30	-0.70	-8.70	-0.10	-0.10
Issuance of Debt	277	156	1,579	161	20	124	-	71	409	274
Effect of Exchange Rate Changes	-15	-	-	-	-	-	-2.50	5.50	-	-25

This table presents Herbalife's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	2,728	2,809	2,732	2,820	3,076	2,679	2,790	2,895	2,565	2,478	2,355
Total Current Assets	1,144	1,399	1,356	1,432	1,776	1,488	1,805	1,860	1,463	1,566	1,393
Cash & Equivalents	415	575	508	602	1,045	839	1,199	1,279	844	890	645
Accounts Receivable	69	81	71	67	83	80	71	93	70	70	84
Inventories, net	475	505	581	576	501	436	382	341	371	332	378
Prepaid Expenses	184	238	197	188	146	133	154	147	177	161	186
Plant, Property, & Equipment, net	460	507	486	442	390	372	360	378	378	339	367
Total Noncurrent Assets	1,124	904	890	946	910	819	625	657	725	572	595
Goodwill	88	95	93	95	101	92	93	97	90	92	102
Intangible Assets	312	314	316	317	313	310	310	310	310	310	310
Noncurrent Deferred & Refundable Income Taxes	399	179	-	-	-	-	-	-	-	-	-
Other Noncurrent Operating Assets	326	315	481	533	496	417	222	250	325	141	155
Total Liabilities & Shareholders' Equity	2,728	2,809	2,732	2,820	3,076	2,679	2,790	2,895	2,565	2,478	2,355
Total Liabilities	3,529	3,870	3,998	4,211	3,932	3,069	3,513	3,230	2,369	2,531	2,689
Total Current Liabilities	1,230	1,278	977	1,080	1,127	964	1,589	907	792	1,024	875
Short-Term Debt	284	310	30	29	23	24	679	102	9.50	230	100
Accounts Payable	70	84	90	92	89	82	81	68	66	71	72
Accrued Expenses	334	343	343	363	358	294	281	278	261	479	503
Other Current Liabilities	543	541	514	596	658	565	547	459	455	-	-
Total Noncurrent Liabilities	2,299	2,592	3,021	3,131	2,805	2,104	1,924	2,323	1,578	1,507	1,815
Long-Term Debt	1,977	2,253	2,663	2,733	2,406	1,779	1,775	2,166	1,438	1,393	1,692
Other Noncurrent Operating Liabilities	322	339	359	398	399	325	150	157	139	71	65
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-801	-1,060	-1,266	-1,392	-856	-390	-723	-335	196	-54	-334
Total Preferred & Common Equity	-801	-1,060	-1,266	-1,392	-856	-390	-723	-335	196	-54	-334
Total Common Equity	-801	-1,060	-1,266	-1,392	-856	-390	-723	-335	196	-54	-334
Common Stock	278	234	189	318	342	367	342	407	468	438	409
Retained Earnings	-808	-1,062	-1,205	-1,169	-687	-215	-526	-248	-66	-326	-665
Accumulated Other Comprehensive Income / (Loss)	-271	-232	-250	-212	-182	-213	-210	-165	-205	-166	-78

This table presents Herbalife's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,654	2,602	2,647	2,725	2,771	2,688	2,725
Total Current Assets	1,245	1,214	1,226	1,346	1,371	1,322	1,384
Cash & Equivalents	403	374	398	496	527	454	533
Accounts Receivable	82	83	88	80	86	85	85
Inventories, net	515	481	502	497	525	545	537
Prepaid Expenses	245	276	238	274	233	238	229
Plant, Property, & Equipment, net	463	468	511	492	486	480	468
Total Noncurrent Assets	946	920	910	886	913	886	874
Goodwill	93	92	94	93	94	94	88
Intangible Assets	313	313	314	314	315	315	316
Other Noncurrent Operating Assets	540	516	502	479	504	476	470
Total Liabilities & Shareholders' Equity	2,654	2,602	2,647	2,725	2,771	2,688	2,725
Total Liabilities	3,608	3,639	3,684	3,828	3,921	3,910	4,087
Total Current Liabilities	1,285	976	945	1,165	1,241	1,227	986
Short-Term Debt	283	22	2.90	233	296	294	30
Accounts Payable	87	81	90	78	89	68	85
Accrued Expenses	332	317	313	335	328	317	329
Other Current Liabilities	583	557	539	520	528	548	543
Total Noncurrent Liabilities	2,323	2,663	2,739	2,663	2,680	2,683	3,102
Long-Term Debt	1,978	2,321	2,405	2,319	2,327	2,335	2,725
Other Noncurrent Operating Liabilities	345	342	334	344	354	348	377
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-954	-1,037	-1,037	-1,104	-1,150	-1,223	-1,362
Total Preferred & Common Equity	-954	-1,037	-1,037	-1,104	-1,150	-1,223	-1,362
Total Common Equity	-954	-1,037	-1,037	-1,104	-1,150	-1,223	-1,362
Common Stock	267	254	244	222	203	191	181
Retained Earnings	-986	-1,033	-1,038	-1,073	-1,115	-1,175	-1,259
Accumulated Other Comprehensive Income / (Loss)	-235	-257	-243	-253	-238	-239	-284

This table displays calculated financial ratios and metrics derived from Herbalife's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-1.37%	-2.73%	-10.31%	4.71%	13.63%	-0.30%	10.48%	-1.35%	0.43%	-9.87%	2.76%
EBITDA Growth	6.71%	-29.70%	-19.72%	10.37%	10.64%	-12.18%	1.61%	27.02%	-16.78%	15.43%	-22.54%
EBIT Growth	5.04%	-35.95%	-21.35%	10.76%	15.97%	-11.73%	1.34%	34.80%	-21.19%	16.14%	-31.93%
NOPAT Growth	132.04%	-39.46%	-29.56%	26.65%	18.09%	-10.32%	55.81%	-14.22%	-19.73%	8.13%	-30.48%
Net Income Growth	78.83%	-55.74%	-28.15%	20.02%	19.81%	4.86%	38.66%	-17.73%	-23.33%	9.85%	-41.48%
EPS Growth	76.06%	-56.04%	-21.79%	49.10%	25.91%	11.11%	53.49%	-17.73%	-23.33%	16.76%	-30.75%
Operating Cash Flow Growth	-20.17%	1.42%	-23.42%	-26.77%	37.40%	-29.44%	9.75%	60.85%	-41.58%	22.94%	-33.83%
Free Cash Flow Firm Growth	92.03%	-8.72%	-23.00%	-32.66%	45.69%	-37.58%	31.44%	107.59%	-62.03%	682.19%	-88.06%
Invested Capital Growth	12.60%	0.96%	19.30%	46.06%	-8.14%	7.92%	-18.81%	-18.20%	17.90%	-16.42%	60.86%
Revenue Q/Q Growth	-0.15%	0.68%	-0.55%	-3.35%	3.56%	0.70%	1.94%	1.10%	-1.18%	-0.78%	-2.66%
EBITDA Q/Q Growth	9.23%	-6.25%	1.81%	-9.26%	5.86%	-10.59%	-0.15%	-0.85%	2.20%	-2.17%	-2.84%
EBIT Q/Q Growth	11.99%	-8.24%	3.22%	-11.11%	6.66%	-11.80%	0.22%	-1.39%	3.53%	-3.61%	-6.15%
NOPAT Q/Q Growth	168.42%	-14.14%	2.01%	-4.85%	4.60%	2.95%	59.44%	-41.05%	4.43%	-4.18%	-1.05%
Net Income Q/Q Growth	193.65%	-23.71%	5.31%	-7.37%	4.81%	2.57%	60.93%	-43.22%	6.08%	-5.28%	-6.12%
EPS Q/Q Growth	194.12%	-24.47%	5.21%	-4.40%	-9.18%	-0.45%	46.67%	-43.22%	6.08%	-8.31%	2.10%
Operating Cash Flow Q/Q Growth	-8.50%	13.49%	-8.27%	-5.56%	-6.56%	4.07%	-6.85%	13.22%	-4.70%	13.26%	-20.76%
Free Cash Flow Firm Q/Q Growth	75.37%	21.36%	-10.63%	-0.73%	-12.54%	4.55%	-0.46%	9.13%	-7.80%	22.21%	-62.15%
Invested Capital Q/Q Growth	15.39%	-2.68%	6.74%	2.46%	9.52%	-7.65%	-7.57%	-24.18%	2.81%	-1.35%	15.11%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	77.88%	76.47%	77.45%	78.64%	79.24%	80.36%	81.21%	80.83%	80.96%	80.85%	80.18%
EBITDA Margin	10.22%	9.44%	13.07%	14.60%	13.85%	14.23%	16.15%	17.56%	13.64%	16.46%	12.85%
Operating Margin	7.73%	7.04%	10.48%	12.65%	11.56%	11.65%	13.96%	13.94%	10.21%	13.06%	10.36%
EBIT Margin	7.52%	7.06%	10.72%	12.23%	11.56%	11.33%	12.79%	13.95%	10.21%	13.01%	10.09%
Profit (Net Income) Margin	5.09%	2.81%	6.17%	7.71%	6.72%	6.38%	6.06%	4.83%	5.79%	7.59%	6.23%
Tax Burden Percent	150.12%	70.05%	75.64%	79.74%	72.15%	68.90%	63.89%	45.39%	71.29%	69.72%	73.27%
Interest Burden Percent	45.13%	56.80%	76.13%	79.04%	80.61%	81.72%	74.18%	76.31%	79.61%	83.67%	84.18%
Effective Tax Rate	-50.12%	29.95%	24.36%	20.26%	27.85%	31.10%	36.11%	54.61%	28.71%	30.28%	26.73%
Return on Invested Capital (ROIC)	58.79%	27.06%	48.87%	90.30%	84.00%	70.84%	73.60%	38.51%	44.17%	54.59%	57.15%
ROIC Less NNEP Spread (ROIC-NNEP)	41.83%	21.91%	44.68%	82.51%	76.36%	63.59%	61.13%	30.20%	34.20%	47.37%	44.86%
Return on Net Nonoperating Assets (RNNOA)	-86.12%	-39.29%	-73.05%	-130.10%	-143.80%	-126.70%	-129.66%	-347.62%	319.98%	-229.43%	227.37%
Return on Equity (ROE)	-27.32%	-12.23%	-24.18%	-39.79%	-59.80%	-55.86%	-56.06%	-309.10%	364.15%	-174.84%	284.52%
Cash Return on Invested Capital (CROIC)	46.94%	26.11%	31.27%	52.86%	92.49%	63.22%	94.35%	58.53%	27.74%	72.47%	10.49%
Operating Return on Assets (OROA)	13.56%	12.90%	20.10%	24.07%	22.26%	20.20%	22.02%	22.62%	18.17%	24.06%	20.73%
Return on Assets (ROA)	9.18%	5.13%	11.57%	15.17%	12.95%	11.37%	10.43%	7.83%	10.31%	14.03%	12.79%
Return on Common Equity (ROCE)	-27.32%	-12.23%	-24.18%	-39.79%	-59.80%	-55.86%	-56.06%	-309.10%	364.15%	-174.84%	284.52%
Return on Equity Simple (ROE_SIMPLE)	-31.74%	-13.41%	-25.38%	-32.14%	-43.52%	-79.74%	-41.00%	-63.91%	132.45%	-633.83%	-92.31%
Net Operating Profit after Tax (NOPAT)	579	250	412	585	462	391	436	280	327	407	376
NOPAT Margin	11.60%	4.93%	7.92%	10.09%	8.34%	8.03%	8.92%	6.33%	7.28%	9.10%	7.59%
Net Nonoperating Expense Percent (NNEP)	16.96%	5.15%	4.19%	7.80%	7.64%	7.25%	12.46%	8.31%	9.97%	7.21%	12.29%
Return On Investment Capital (ROIC_SIMPLE)	39.71%	16.62%	28.92%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	22.12%	23.53%	22.55%	21.36%	20.76%	19.64%	18.79%	19.17%	19.04%	19.15%	19.82%
SG&A Expenses to Revenue	37.56%	36.86%	34.79%	34.67%	37.44%	39.78%	39.97%	39.72%	43.82%	39.93%	40.15%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	70.15%	69.43%	66.97%	65.99%	67.68%	68.71%	67.24%	66.90%	70.75%	67.79%	69.82%
Earnings before Interest and Taxes (EBIT)	375	357	558	710	641	552	626	618	458	581	501
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	510	478	680	847	768	694	790	778	612	736	637
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	22.82	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.14	0.30	0.28	0.79	1.14	1.44	1.88	1.33	1.00	1.11	0.70
Price to Earnings (P/E)	2.65	10.64	4.53	10.26	16.97	25.11	31.03	27.61	17.23	14.63	11.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.18%
Earnings Yield	37.71%	9.40%	22.06%	9.74%	5.89%	3.98%	3.22%	3.62%	5.80%	6.83%	8.92%
Enterprise Value to Invested Capital (EV/IC)	2.41	3.78	3.97	8.77	14.63	13.92	19.68	10.53	6.35	8.39	5.67
Enterprise Value to Revenue (EV/Rev)	0.50	0.69	0.70	1.16	1.39	1.64	2.14	1.56	1.13	1.27	0.93
Enterprise Value to EBITDA (EV/EBITDA)	4.94	7.32	5.35	7.97	10.04	11.51	13.24	8.87	8.30	7.74	7.23
Enterprise Value to EBIT (EV/EBIT)	6.71	9.79	6.52	9.51	12.03	14.46	16.71	11.16	11.10	9.80	9.21
Enterprise Value to NOPAT (EV/NOPAT)	4.35	14.02	8.83	11.53	16.67	20.40	23.96	24.61	15.56	13.99	12.24
Enterprise Value to Operating Cash Flow (EV/OCF)	8.83	9.79	10.33	14.67	12.26	17.45	16.13	11.67	13.84	9.06	9.01
Enterprise Value to Free Cash Flow (EV/FCFF)	5.45	14.53	13.80	19.70	15.14	22.86	18.69	16.19	24.79	10.54	66.72
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-2.82	-2.42	-2.13	-1.99	-2.84	-4.62	-3.39	-6.78	7.38	-30.32	-5.36
Long-Term Debt to Equity	-2.47	-2.12	-2.10	-1.96	-2.81	-4.56	-2.45	-6.47	7.33	-26.03	-5.06
Financial Leverage	-2.06	-1.79	-1.64	-1.58	-1.88	-1.99	-2.12	-11.51	9.36	-4.84	5.07
Leverage Ratio	-2.97	-2.38	-2.09	-2.62	-4.62	-4.91	-5.37	-39.45	35.32	-12.46	22.25
Compound Leverage Factor	-1.34	-1.35	-1.59	-2.07	-3.72	-4.01	-3.99	-30.11	28.12	-10.43	18.73
Debt to Total Capital	154.91%	170.59%	188.77%	201.49%	154.45%	127.60%	141.81%	117.31%	88.06%	103.41%	122.95%
Short-Term Debt to Total Capital	19.43%	20.60%	2.07%	2.14%	1.46%	1.71%	39.23%	5.30%	0.58%	14.63%	6.86%
Long-Term Debt to Total Capital	135.48%	149.98%	186.70%	199.34%	152.99%	125.90%	102.57%	112.02%	87.48%	88.78%	116.08%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-54.91%	-70.59%	-88.77%	-101.49%	-54.45%	-27.60%	-41.81%	-17.31%	11.94%	-3.41%	-22.95%
Debt to EBITDA	4.43	5.36	3.96	3.26	3.16	2.60	3.11	2.92	2.37	2.21	2.81
Net Debt to EBITDA	3.62	4.16	3.21	2.55	1.80	1.39	1.59	1.27	0.99	1.00	1.80
Long-Term Debt to EBITDA	3.87	4.71	3.91	3.23	3.13	2.56	2.25	2.79	2.35	1.89	2.66
Debt to NOPAT	3.90	10.26	6.53	4.72	5.25	4.61	5.62	8.10	4.43	3.99	4.76
Net Debt to NOPAT	3.18	7.96	5.30	3.69	2.99	2.46	2.88	3.53	1.85	1.80	3.05
Long-Term Debt to NOPAT	3.41	9.02	6.46	4.67	5.20	4.54	4.07	7.73	4.40	3.42	4.50
Altman Z-Score	1.95	1.98	2.35	3.11	3.39	4.00	3.89	3.61	3.75	3.83	3.45
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.93	1.10	1.39	1.33	1.58	1.54	1.14	2.05	1.85	1.53	1.59
Quick Ratio	0.39	0.51	0.59	0.62	1.00	0.95	0.80	1.51	1.16	0.94	0.83
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	463	241	264	343	509	349	560	426	205	540	69
Operating Cash Flow to CapEx	233.93%	264.81%	225.38%	304.03%	561.25%	431.20%	771.90%	618.64%	256.14%	795.82%	271.01%
Free Cash Flow to Firm to Interest Expense	2.12	1.45	1.89	2.24	3.83	2.28	3.09	2.65	2.07	5.37	0.75
Operating Cash Flow to Interest Expense	1.31	2.15	2.53	3.01	4.73	2.99	3.58	3.67	3.70	6.26	5.58
Operating Cash Flow Less CapEx to Interest Expense	0.75	1.34	1.41	2.02	3.88	2.30	3.12	3.08	2.25	5.47	3.52
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.80	1.83	1.87	1.97	1.93	1.78	1.72	1.62	1.78	1.85	2.05
Accounts Receivable Turnover	66.53	66.70	75.70	77.27	68.00	64.94	59.73	54.13	64.03	58.23	53.93
Inventory Turnover	2.25	2.19	2.03	2.30	2.45	2.34	2.54	2.38	2.43	2.41	2.70
Fixed Asset Turnover	10.33	10.20	11.21	13.94	14.55	13.33	13.27	11.72	12.52	12.66	14.47
Accounts Payable Turnover	14.34	13.71	12.91	13.72	13.51	11.78	12.35	12.68	12.47	11.93	12.67
Days Sales Outstanding (DSO)	5.49	5.47	4.82	4.72	5.37	5.62	6.11	6.74	5.70	6.27	6.77
Days Inventory Outstanding (DIO)	162.06	166.40	179.83	158.61	148.72	155.83	143.53	153.23	150.19	151.31	135.34
Days Payable Outstanding (DPO)	25.45	26.63	28.27	26.61	27.01	30.99	29.56	28.78	29.28	30.59	28.80
Cash Conversion Cycle (CCC)	142.09	145.24	156.38	136.73	127.07	130.46	120.08	131.20	126.61	126.98	113.31
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,044	927	918	770	527	574	532	655	800	679	812
Invested Capital Turnover	5.07	5.49	6.17	8.95	10.07	8.83	8.25	6.09	6.07	6.00	7.53
Increase / (Decrease) in Invested Capital	117	8.80	149	243	-47	42	-123	-146	122	-133	307
Enterprise Value (EV)	2,519	3,500	3,641	6,751	7,707	7,985	10,458	6,894	5,083	5,694	4,607
Market Capitalization	674	1,512	1,457	4,590	6,324	7,021	9,203	5,905	4,479	4,962	3,461
Book Value per Share	($7.95)	($10.70)	($12.93)	($12.41)	($6.50)	($2.65)	($4.63)	($3.84)	$2.11	($0.58)	($3.64)
Tangible Book Value per Share	($11.92)	($14.83)	($17.11)	($16.09)	($9.65)	($5.37)	($7.22)	($8.51)	($2.19)	($4.92)	($8.14)
Total Capital	1,459	1,502	1,426	1,371	1,572	1,413	1,730	1,933	1,644	1,569	1,457
Total Debt	2,260	2,562	2,692	2,763	2,428	1,803	2,454	2,268	1,448	1,622	1,792
Total Long-Term Debt	1,977	2,253	2,663	2,733	2,406	1,779	1,775	2,166	1,438	1,393	1,692
Net Debt	1,845	1,987	2,184	2,161	1,383	964	1,255	989	604	732	1,146
Capital Expenditures (CapEx)	122	135	156	151	112	106	84	96	143	79	189
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-219	-144	-99	-221	-374	-292	-304	-223	-164	-118	-27
Debt-free Net Working Capital (DFNWC)	197	431	409	381	671	548	895	1,056	681	771	619
Net Working Capital (NWC)	-87	122	380	351	649	524	216	954	671	542	519
Net Nonoperating Expense (NNE)	325	107	91	138	90	80	140	66	67	68	68
Net Nonoperating Obligations (NNO)	1,845	1,987	2,184	2,161	1,383	964	1,255	989	604	732	1,146
Total Depreciation and Amortization (D&A)	135	121	122	138	127	141	164	160	154	154	137
Debt-free, Cash-free Net Working Capital to Revenue	-4.38%	-2.84%	-1.90%	-3.80%	-6.75%	-5.98%	-6.21%	-5.03%	-3.64%	-2.65%	-0.54%
Debt-free Net Working Capital to Revenue	3.94%	8.52%	7.86%	6.56%	12.12%	11.23%	18.30%	23.85%	15.16%	17.26%	12.48%
Net Working Capital to Revenue	-1.74%	2.40%	7.29%	6.06%	11.70%	10.74%	4.42%	21.53%	14.95%	12.13%	10.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.53	$1.44	$3.26	$4.22	$2.83	$2.26	$2.12	$1.35	$1.57	$2.06	$1.79
Adjusted Weighted Average Basic Shares Outstanding	100.60M	99M	98.50M	105.90M	131.50M	137.40M	140.20M	158.40M	166M	165.20M	172.60M
Adjusted Diluted Earnings per Share	$2.50	$1.42	$3.23	$4.13	$2.77	$2.20	$1.98	$1.29	$1.51	$1.99	$1.70
Adjusted Weighted Average Diluted Shares Outstanding	101.60M	100.20M	99.50M	108.30M	134.50M	141.60M	149.50M	165.80M	172.20M	170.60M	181.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	101.20M	99.26M	97.92M	109.77M	117.92M	147.53M	152.86M	174.84M	186.17M	185.35M	184.25M
Normalized Net Operating Profit after Tax (NOPAT)	270	250	412	585	462	391	436	432	327	407	376
Normalized NOPAT Margin	5.41%	4.93%	7.92%	10.09%	8.34%	8.03%	8.92%	9.76%	7.28%	9.10%	7.59%
Pre Tax Income Margin	3.39%	4.01%	8.16%	9.66%	9.32%	9.26%	9.49%	10.64%	8.13%	10.88%	8.50%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.72	2.15	4.01	4.63	4.82	3.61	3.46	3.84	4.61	5.78	5.46
NOPAT to Interest Expense	2.65	1.50	2.96	3.82	3.48	2.56	2.41	1.74	3.29	4.05	4.10
EBIT Less CapEx to Interest Expense	1.16	1.34	2.88	3.65	3.97	2.92	2.99	3.25	3.17	5.00	3.40
NOPAT Less CapEx to Interest Expense	2.09	0.69	1.84	2.83	2.63	1.86	1.95	1.15	1.84	3.26	2.05
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	9.85%
Augmented Payout Ratio	3.26%	7.74%	45.66%	226.14%	247.85%	5.37%	252.97%	394.67%	5.08%	4.90%	428.34%

This table displays calculated financial ratios and metrics derived from Herbalife's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.63%	-3.20%	-2.50%	0.97%	2.90%	-1.07%	-5.65%	-6.27%	-2.38%	-9.49%
EBITDA Growth	62.40%	17.03%	-31.35%	3.41%	-27.69%	-22.34%	-17.34%	-45.76%	-0.59%	-20.67%
EBIT Growth	90.86%	18.01%	-43.35%	1.99%	-37.23%	-26.93%	-20.80%	-53.95%	5.46%	-22.18%
NOPAT Growth	1,020.16%	29.31%	-64.38%	-22.63%	-57.18%	-38.51%	-19.92%	-45.48%	11.00%	-26.78%
Net Income Growth	1,644.12%	10.75%	-92.15%	-17.06%	-81.25%	-47.93%	-30.75%	-70.16%	42.41%	-29.98%
EPS Growth	1,650.00%	6.98%	-91.67%	-17.24%	-82.14%	-48.19%	-31.82%	-69.79%	40.00%	-23.85%
Operating Cash Flow Growth	-27.58%	25.00%	-24.41%	-70.13%	79.29%	14.37%	37.25%	-64.60%	-37.24%	-20.91%
Free Cash Flow Firm Growth	942.12%	606.47%	199.63%	132.86%	131.82%	-1,464.63%	17.25%	-44.82%	58.07%	98.64%
Invested Capital Growth	12.60%	-5.03%	-1.46%	2.20%	0.96%	10.73%	16.22%	20.08%	19.30%	14.51%
Revenue Q/Q Growth	-2.65%	-3.18%	1.33%	4.06%	-5.17%	-2.49%	4.94%	6.04%	-8.83%	-7.01%
EBITDA Q/Q Growth	-13.62%	52.36%	2.71%	20.14%	-37.75%	-10.62%	54.71%	-15.99%	-33.15%	-4.87%
EBIT Q/Q Growth	-16.21%	81.83%	-2.78%	28.85%	-48.19%	-12.72%	75.04%	-20.70%	-39.69%	-5.39%
NOPAT Q/Q Growth	322.11%	175.50%	-39.72%	59.81%	-51.27%	-24.11%	30.93%	-11.55%	-30.03%	-1.18%
Net Income Q/Q Growth	275.32%	908.51%	-80.66%	138.24%	-76.17%	-28.55%	104.44%	-46.14%	-33.82%	-4.97%
EPS Q/Q Growth	280.43%	820.00%	-79.17%	140.00%	-76.74%	-28.33%	106.90%	-48.21%	-32.53%	-5.68%
Operating Cash Flow Q/Q Growth	-30.05%	-2.93%	642.75%	-85.64%	20.73%	-41.30%	193.51%	-13.81%	-22.99%	-29.55%
Free Cash Flow Firm Q/Q Growth	82.68%	197.57%	46.86%	30.53%	188.78%	41.46%	51.56%	-26.40%	-4,265.90%	96.90%
Invested Capital Q/Q Growth	15.39%	-2.90%	-4.27%	4.97%	-2.68%	0.75%	-0.71%	3.70%	6.74%	5.74%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	77.85%	78.34%	77.90%	77.46%	76.33%	76.34%	77.05%	76.15%	77.51%	77.99%
EBITDA Margin	11.55%	13.02%	8.27%	8.16%	7.07%	10.77%	11.75%	7.97%	10.06%	13.72%
Operating Margin	8.82%	10.25%	6.28%	5.69%	4.59%	8.33%	9.39%	5.63%	7.53%	11.38%
EBIT Margin	8.82%	10.25%	5.46%	5.69%	4.59%	8.41%	9.39%	5.63%	7.53%	11.38%
Profit (Net Income) Margin	14.73%	3.82%	0.37%	1.92%	0.84%	3.34%	4.56%	2.34%	4.61%	6.35%
Tax Burden Percent	338.21%	67.14%	38.52%	71.47%	57.63%	61.85%	70.47%	94.21%	84.47%	72.81%
Interest Burden Percent	49.39%	55.55%	17.45%	47.29%	31.72%	64.25%	68.88%	44.11%	72.44%	76.59%
Effective Tax Rate	-238.21%	32.86%	61.48%	28.53%	42.37%	38.15%	29.53%	5.79%	15.53%	27.19%
Return on Invested Capital (ROIC)	151.18%	37.06%	12.99%	21.43%	14.52%	28.58%	37.95%	31.13%	39.22%	53.83%
ROIC Less NNEP Spread (ROIC-NNEP)	141.66%	35.12%	11.70%	20.13%	13.47%	27.49%	36.69%	29.45%	38.27%	52.66%
Return on Net Nonoperating Assets (RNNOA)	-291.64%	-66.81%	-21.73%	-37.29%	-24.16%	-47.70%	-61.85%	-48.66%	-62.58%	-84.14%
Return on Equity (ROE)	-140.46%	-29.75%	-8.74%	-15.86%	-9.63%	-19.13%	-23.90%	-17.53%	-23.35%	-30.31%
Cash Return on Invested Capital (CROIC)	46.94%	28.40%	22.14%	22.60%	26.11%	21.90%	22.65%	22.00%	31.27%	36.65%
Operating Return on Assets (OROA)	15.91%	19.06%	10.24%	10.82%	8.39%	15.51%	16.99%	10.46%	14.12%	21.36%
Return on Assets (ROA)	26.57%	7.11%	0.69%	3.66%	1.53%	6.16%	8.25%	4.35%	8.64%	11.91%
Return on Common Equity (ROCE)	-140.46%	-29.75%	-8.74%	-15.86%	-9.63%	-19.13%	-23.90%	-17.53%	-23.35%	-30.31%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-9.08%	-7.91%	-13.24%	0.00%	-16.89%	-19.63%	-20.64%	0.00%	-22.40%
Net Operating Profit after Tax (NOPAT)	360	85	31	51	32	66	87	66	75	107
NOPAT Margin	29.83%	6.88%	2.42%	4.06%	2.65%	5.15%	6.62%	5.30%	6.36%	8.29%
Net Nonoperating Expense Percent (NNEP)	9.51%	1.94%	1.29%	1.29%	1.05%	1.08%	1.25%	1.68%	0.95%	1.17%
Return On Investment Capital (ROIC_SIMPLE)	24.69%	-	-	-	2.14%	-	-	-	5.27%	-
Cost of Revenue to Revenue	22.16%	21.66%	22.10%	22.54%	23.67%	23.66%	22.95%	23.85%	22.49%	22.01%
SG&A Expenses to Revenue	36.19%	35.80%	39.21%	38.93%	39.04%	35.53%	35.05%	38.01%	37.03%	34.61%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	69.02%	68.09%	71.63%	71.77%	71.74%	68.01%	67.66%	70.52%	69.98%	66.60%
Earnings before Interest and Taxes (EBIT)	107	127	70	72	56	108	123	71	89	147
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	140	162	106	103	86	138	154	100	119	178
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.14	0.14	0.21	0.20	0.30	0.28	0.26	0.31	0.28	0.41
Price to Earnings (P/E)	2.65	8.36	12.67	7.26	10.64	7.43	5.80	6.25	4.53	11.97
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	37.71%	11.96%	7.89%	13.77%	9.40%	13.46%	17.24%	16.01%	22.06%	8.36%
Enterprise Value to Invested Capital (EV/IC)	2.41	2.86	3.23	3.09	3.78	3.61	3.60	3.94	3.97	5.08
Enterprise Value to Revenue (EV/Rev)	0.50	0.52	0.60	0.59	0.69	0.68	0.68	0.73	0.70	0.83
Enterprise Value to EBITDA (EV/EBITDA)	4.94	5.53	6.79	6.26	7.32	6.75	6.18	6.43	5.35	6.54
Enterprise Value to EBIT (EV/EBIT)	6.71	7.71	9.55	8.40	9.79	8.83	7.92	8.11	6.52	8.08
Enterprise Value to NOPAT (EV/NOPAT)	4.35	11.97	15.51	12.61	14.02	11.83	10.29	10.68	8.83	10.80
Enterprise Value to Operating Cash Flow (EV/OCF)	8.83	8.28	10.30	9.25	9.79	10.92	11.17	13.99	10.33	11.36
Enterprise Value to Free Cash Flow (EV/FCFF)	5.45	9.79	14.48	13.82	14.53	17.34	17.10	19.54	13.80	14.79
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-2.82	-2.37	-2.26	-2.32	-2.42	-2.31	-2.28	-2.15	-2.13	-2.02
Long-Term Debt to Equity	-2.47	-2.07	-2.24	-2.32	-2.12	-2.10	-2.02	-1.91	-2.10	-2.00
Financial Leverage	-2.06	-1.90	-1.86	-1.85	-1.79	-1.74	-1.69	-1.65	-1.64	-1.60
Leverage Ratio	-2.97	-2.61	-2.46	-2.36	-2.38	-2.21	-2.17	-2.06	-2.09	-2.07
Compound Leverage Factor	-1.47	-1.45	-0.43	-1.12	-0.76	-1.42	-1.50	-0.91	-1.51	-1.59
Debt to Total Capital	154.91%	173.01%	179.45%	175.59%	170.59%	176.20%	178.16%	186.95%	188.77%	197.80%
Short-Term Debt to Total Capital	19.43%	21.68%	1.66%	0.21%	20.60%	16.06%	20.10%	20.88%	2.07%	2.12%
Long-Term Debt to Total Capital	135.48%	151.33%	177.79%	175.38%	149.98%	160.14%	158.06%	166.07%	186.70%	195.68%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-54.91%	-73.01%	-79.45%	-75.59%	-70.59%	-76.20%	-78.16%	-86.95%	-88.77%	-97.80%
Debt to EBITDA	4.43	4.84	5.29	5.01	5.36	5.00	4.76	4.51	3.96	4.12
Net Debt to EBITDA	3.62	3.98	4.45	4.18	4.16	4.03	3.81	3.73	3.21	3.33
Long-Term Debt to EBITDA	3.87	4.23	5.24	5.01	4.71	4.55	4.22	4.01	3.91	4.08
Debt to NOPAT	3.90	10.48	12.08	10.10	10.26	8.78	7.92	7.49	6.53	6.81
Net Debt to NOPAT	3.18	8.61	10.15	8.43	7.96	7.07	6.33	6.19	5.30	5.50
Long-Term Debt to NOPAT	3.41	9.16	11.97	10.09	9.02	7.98	7.03	6.65	6.46	6.74
Altman Z-Score	1.62	1.62	1.75	1.75	1.62	1.72	1.66	1.66	1.78	1.94
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.93	0.97	1.24	1.30	1.10	1.16	1.11	1.08	1.39	1.40
Quick Ratio	0.39	0.38	0.47	0.51	0.51	0.49	0.49	0.44	0.59	0.63
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	243	133	45	30	23	-26	-45	-93	-73	-1.68
Operating Cash Flow to CapEx	270.82%	367.16%	282.37%	41.95%	272.24%	255.95%	354.05%	152.48%	125.23%	184.62%
Free Cash Flow to Firm to Interest Expense	3.68	2.36	0.78	0.80	0.47	-0.68	-1.17	-2.35	-1.69	-0.05
Operating Cash Flow to Interest Expense	1.05	1.76	1.78	0.36	1.94	2.07	3.53	1.17	1.24	2.02
Operating Cash Flow Less CapEx to Interest Expense	0.66	1.28	1.15	-0.50	1.23	1.26	2.53	0.40	0.25	0.92
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.80	1.86	1.88	1.90	1.83	1.85	1.81	1.86	1.87	1.88
Accounts Receivable Turnover	66.53	61.93	59.63	58.67	66.70	61.13	59.42	60.56	75.70	61.24
Inventory Turnover	2.25	2.22	2.30	2.25	2.19	2.26	2.13	2.09	2.03	2.20
Fixed Asset Turnover	10.33	10.47	10.57	10.24	10.20	10.47	10.60	10.97	11.21	11.90
Accounts Payable Turnover	14.34	13.67	13.64	14.92	13.71	14.40	12.15	14.72	12.91	13.14
Days Sales Outstanding (DSO)	5.49	5.89	6.12	6.22	5.47	5.97	6.14	6.03	4.82	5.96
Days Inventory Outstanding (DIO)	162.06	164.27	158.39	162.29	166.40	161.39	171.16	174.67	179.83	166.17
Days Payable Outstanding (DPO)	25.45	26.70	26.76	24.46	26.63	25.35	30.03	24.80	28.27	27.79
Cash Conversion Cycle (CCC)	142.09	143.47	137.76	144.05	145.24	142.01	147.27	155.90	156.38	144.34
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,044	905	932	973	927	952	945	952	918	860
Invested Capital Turnover	5.07	5.39	5.37	5.27	5.49	5.55	5.73	5.87	6.17	6.50
Increase / (Decrease) in Invested Capital	117	-48	-14	21	8.80	92	132	159	149	109
Enterprise Value (EV)	2,519	2,583	3,007	3,006	3,500	3,441	3,405	3,751	3,641	4,367
Market Capitalization	674	724	1,039	996	1,512	1,385	1,310	1,577	1,457	2,145
Book Value per Share	($7.95)	($9.47)	($10.38)	($10.40)	($10.70)	($11.15)	($11.63)	($12.49)	($12.93)	($12.63)
Tangible Book Value per Share	($11.92)	($13.50)	($14.42)	($14.48)	($14.83)	($15.26)	($15.77)	($16.67)	($17.11)	($16.37)
Total Capital	1,459	1,307	1,306	1,371	1,502	1,448	1,472	1,406	1,426	1,393
Total Debt	2,260	2,261	2,343	2,408	2,562	2,552	2,622	2,629	2,692	2,755
Total Long-Term Debt	1,977	1,978	2,321	2,405	2,253	2,319	2,327	2,335	2,663	2,725
Net Debt	1,845	1,859	1,969	2,010	1,987	2,056	2,096	2,175	2,184	2,222
Capital Expenditures (CapEx)	26	27	36	33	35	31	38	30	43	38
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-219	-160	-115	-114	-144	-82	-100	-66	-99	-105
Debt-free Net Working Capital (DFNWC)	197	243	259	284	431	413	426	389	409	428
Net Working Capital (NWC)	-87	-40	238	282	122	181	131	95	380	398
Net Nonoperating Expense (NNE)	182	38	26	27	22	23	27	37	21	25
Net Nonoperating Obligations (NNO)	1,845	1,859	1,969	2,010	1,987	2,056	2,096	2,175	2,184	2,222
Total Depreciation and Amortization (D&A)	33	34	36	31	30	30	31	29	30	30
Debt-free, Cash-free Net Working Capital to Revenue	-4.38%	-3.19%	-2.28%	-2.24%	-2.84%	-1.64%	-1.99%	-1.28%	-1.90%	-2.00%
Debt-free Net Working Capital to Revenue	3.94%	4.86%	5.14%	5.60%	8.52%	8.22%	8.46%	7.59%	7.86%	8.17%
Net Working Capital to Revenue	-1.74%	-0.81%	4.71%	5.55%	2.40%	3.59%	2.59%	1.86%	7.29%	7.61%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.77	$0.47	$0.05	$0.24	$0.11	$0.43	$0.60	$0.30	$0.56	$0.84
Adjusted Weighted Average Basic Shares Outstanding	100.60M	100.90M	100.60M	99.70M	99M	99.20M	99.10M	98.50M	98.50M	98M
Adjusted Diluted Earnings per Share	$1.75	$0.46	$0.05	$0.24	$0.10	$0.43	$0.60	$0.29	$0.56	$0.83
Adjusted Weighted Average Diluted Shares Outstanding	101.60M	101.90M	101.70M	100.70M	100.20M	100.40M	99.50M	100.20M	99.50M	98.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	101.20M	100.79M	100.72M	99.97M	99.26M	99.11M	99.00M	98.92M	97.92M	97.88M
Normalized Net Operating Profit after Tax (NOPAT)	75	85	56	51	32	66	87	66	75	107
Normalized NOPAT Margin	6.17%	6.88%	4.39%	4.06%	2.65%	5.15%	6.62%	5.30%	6.36%	8.29%
Pre Tax Income Margin	4.36%	5.69%	0.95%	2.69%	1.46%	5.40%	6.47%	2.48%	5.45%	8.72%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.61	2.25	1.21	1.90	1.13	2.80	3.21	1.79	2.05	4.27
NOPAT to Interest Expense	5.44	1.51	0.54	1.36	0.65	1.71	2.26	1.69	1.73	3.11
EBIT Less CapEx to Interest Expense	1.22	1.77	0.58	1.03	0.41	1.99	2.22	1.02	1.06	3.18
NOPAT Less CapEx to Interest Expense	5.05	1.03	-0.09	0.49	-0.06	0.91	1.27	0.92	0.74	2.02
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	3.26%	8.08%	8.90%	3.35%	7.74%	5.26%	4.25%	15.53%	45.66%	81.51%

Frequently Asked Questions About Herbalife's Financials

When does Herbalife's financial year end?

According to the most recent income statement we have on file, Herbalife's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Herbalife's net income changed over the last 10 years?

The last 5 years of Herbalife's net income performance:

2020: $372.60 million
2021: $447.20 million
2022: $321.30 million
2023: $142.20 million
2024: $254.30 million

Find out what analysts predict for Herbalife in the coming months.

What is Herbalife's operating income?

Herbalife's total operating income in 2024 was $385.90 million, based on the following breakdown:

Total Gross Profit: $3.89 billion
Total Operating Expenses: $3.50 billion

How has Herbalife revenue changed over the last 10 years?

Over the last 10 years, Herbalife's total revenue changed from $4.96 billion in 2014 to $4.99 billion in 2024, a change of 0.7%.

How much debt does Herbalife have?

Herbalife's total liabilities were at $3.53 billion at the end of 2024, a 8.8% decrease from 2023, and a 31.2% increase since 2014.

How much cash does Herbalife have?

In the past 10 years, Herbalife's cash and equivalents has ranged from $415.30 million in 2024 to $1.28 billion in 2017, and is currently $415.30 million as of their latest financial filing in 2024.

How has Herbalife's book value per share changed over the last 10 years?

Over the last 10 years, Herbalife's book value per share changed from -3.64 in 2014 to -7.95 in 2024, a change of 118.2%.

Related Companies

This page (NYSE:HLF) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Herbalife (HLF) Financials

Frequently Asked Questions About Herbalife's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Herbalife (HLF) Financials

Annual Income Statements for Herbalife

Quarterly Income Statements for Herbalife

Annual Cash Flow Statements for Herbalife

Quarterly Cash Flow Statements for Herbalife

Annual Balance Sheets for Herbalife

Quarterly Balance Sheets for Herbalife

Annual Metrics And Ratios for Herbalife

Quarterly Metrics And Ratios for Herbalife

Frequently Asked Questions About Herbalife's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools